Veraxa Biotech Holding AG (VRXA) Notes Payables (2025)

Veraxa Biotech Holding AG's (VRXA) quarterly Notes Payables came in at $1.3 million in Q4 2025.

Veraxa Biotech Holding AG (VRXA) Notes Payables (2025) Analysis & Trends

Veraxa Biotech Holding AG (VRXA) has 1 years of Notes Payables data on file, last reported at $1.3 million in Q4 2025.

On a quarterly basis, Notes Payables changed N/A year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $1.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.3 million, changed N/A from the prior year.
Notes Payables for Q4 2025 stood at $1.3 million.
Over the last five years, Notes Payables for VRXA reached as high as $1.3 million in Q4 2025 and fell as low as $1.3 million in Q4 2025.

Download Data

Date	Value
Dec 31, 2025	1.25 Mn